Eliem Therapeutics - 3 Year Stock Price History | CLYM
Historical daily share price chart and data for Eliem Therapeutics since 2021 adjusted for splits and dividends. The latest closing stock price for Eliem Therapeutics as of October 03, 2024 is 5.10.
- The all-time high Eliem Therapeutics stock closing price was 28.61 on September 07, 2021.
- The Eliem Therapeutics 52-week high stock price is 11.55, which is 126.5% above the current share price.
- The Eliem Therapeutics 52-week low stock price is 2.35, which is 53.9% below the current share price.
- The average Eliem Therapeutics stock price for the last 52 weeks is 4.84.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Eliem Therapeutics Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2024 |
5.5247 |
2.8000 |
10.2000 |
2.5400 |
5.1000 |
88.89% |
| 2023 |
2.9492 |
3.3100 |
4.6400 |
2.3000 |
2.7000 |
-26.43% |
| 2022 |
5.0292 |
10.8900 |
13.1500 |
2.4800 |
3.6700 |
-64.91% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.342B |
$0.000B |
|
Eliem Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc. is based in SEATTLE, United Kingdom.
|
